Tilray Brands (TLRY) Goodwill & Intangibles (2017 - 2026)
Tilray Brands' (TLRY) quarterly Goodwill & Intangibles came in at $810.3 million in Q2 2026, down 81.88% YoY from $4.5 billion in Q2 2025, and up 2.58% on a QoQ basis from $790.0 million in Q1 2026.
Tilray Brands (TLRY) Goodwill & Intangibles (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Goodwill & Intangibles data on file, last reported at $810.3 million in Q2 2026.
- Quarterly Goodwill & Intangibles fell 81.88% year-over-year to $810.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $810.3 million (down 81.88% YoY) and the FY2026 annual result came in at $810.3 million, down 81.88% from the prior year.
- Goodwill & Intangibles grew to $810.3 million in Q2 2026, from $790.0 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $4.5 billion in Q1 2022 to a low of $785.3 million in Q4 2025.
- A 5-year average of $3.1 billion and a median of $3.6 billion in 2023 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2024 — Goodwill & Intangibles rose 23.73% — and 2026, when it sank 81.88%.
- Tracing TLRY's Goodwill & Intangibles over 5 years: stood at $4.2 billion in 2022, then fell by 14.78% to $3.6 billion in 2023, then dropped by 0.87% to $3.6 billion in 2024, then sank by 78.05% to $785.3 million in 2025, then increased by 3.19% to $810.3 million in 2026.
- The last three Goodwill & Intangibles figures came in at $810.3 million (Q2 2026), $790.0 million (Q1 2026), and $785.3 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Tilray Brands | 513.87 Mn | 279.24 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 810.35 Mn |
| Feb 28, 2026 | 789.98 Mn |
| Nov 30, 2025 | 785.29 Mn |
| Aug 31, 2025 | 786.19 Mn |
| May 31, 2025 | 4.47 Bn |
| Feb 28, 2025 | 1.57 Bn |
| Nov 30, 2024 | 3.58 Bn |
| Aug 31, 2024 | 3.62 Bn |
| May 31, 2024 | 4.44 Bn |
| Feb 29, 2024 | 3.60 Bn |
| Nov 30, 2023 | 3.61 Bn |
| Aug 31, 2023 | 3.60 Bn |
| May 31, 2023 | 3.59 Bn |
| Feb 28, 2023 | 3.59 Bn |
| Nov 30, 2022 | 4.23 Bn |
| Aug 31, 2022 | 4.21 Bn |
| May 31, 2022 | 4.28 Bn |
| Feb 28, 2022 | 4.49 Bn |
| Nov 30, 2021 | 4.37 Bn |
| Aug 31, 2021 | 3.72 Bn |